# Corbus Pharmaceuticals Holdings, Inc. (CRBP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CRBP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -58.01M | $ -55.21M | $ 4.26M | $ 102.24M |
| 2025 | $ 0 | $ -80.41M | $ -66.04M | $ 1.63M | $ 147.50M |
| 2024 | $ 0 | $ -42.26M | $ -43.93M | $ 3.24M | $ 142.43M |
| 2023 | $ 0 | $ -48.23M | $ -39.03M | $ 20.89M | $ -6.91M |
| 2022 | $ 0 | $ -47.31M | $ -41.96M | $ 25.09M | $ 32.99M |
| 2021 | $ 1.05M | $ -54.25M | $ -57.34M | $ 26.59M | $ 69.11M |
| 2020 | $ 5.02M | $ -141.75M | $ -127.61M | $ 26.84M | $ 45.27M |
| 2019 | $ 46.65M | $ -92.23M | $ -62.55M | $ 9.45M | $ 6.16M |
| 2018 | $ 6.37M | $ -73.53M | $ -42.75M | $ 394.3K | $ 27.52M |
| 2017 | $ 0 | $ -43.68M | $ -38.40M | $ 333.2K | $ 57.78M |
| 2016 | $ 2.63M | $ -27.51M | $ -19.16M | $ 276.4K | $ 8.92M |
| 2015 | $ 910.4K | $ -12.43M | $ -6.69M | $ 162.0K | $ 8.99M |
| 2014 | $ 0 | $ -3.59M | $ -3.44M | $ 144.4K | $ 5.86M |
| 2013 | $ 0 | $ -794.8K | $ -175.6K | $ 638.1K | $ -1.78M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.24 |
| Current Ratio | 5.71 |

## Other views

- [Metrics](https://sponda.capital/en/CRBP.md)
- [Charts](https://sponda.capital/en/CRBP/charts.md)
- [Compare](https://sponda.capital/en/CRBP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.